chr10-129628693-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002412.5(MGMT):c.126-79202T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 152,028 control chromosomes in the GnomAD database, including 14,218 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.42 ( 14218 hom., cov: 33)
Consequence
MGMT
NM_002412.5 intron
NM_002412.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0690
Publications
9 publications found
Genes affected
MGMT (HGNC:7059): (O-6-methylguanine-DNA methyltransferase) Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.605 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MGMT | NM_002412.5 | c.126-79202T>G | intron_variant | Intron 2 of 4 | ENST00000651593.1 | NP_002403.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.419 AC: 63617AN: 151910Hom.: 14216 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
63617
AN:
151910
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.419 AC: 63630AN: 152028Hom.: 14218 Cov.: 33 AF XY: 0.417 AC XY: 31005AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
63630
AN:
152028
Hom.:
Cov.:
33
AF XY:
AC XY:
31005
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
10766
AN:
41474
American (AMR)
AF:
AC:
6811
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1726
AN:
3472
East Asian (EAS)
AF:
AC:
3218
AN:
5162
South Asian (SAS)
AF:
AC:
2661
AN:
4820
European-Finnish (FIN)
AF:
AC:
4149
AN:
10560
Middle Eastern (MID)
AF:
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32809
AN:
67946
Other (OTH)
AF:
AC:
950
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1840
3681
5521
7362
9202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1912
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.